Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$2.16M Sell
24,892
-11,731
-32% -$964K 0.84% 26
2019
Q3
$2.94M Sell
36,623
-60
-0.2% -$4.81K 0.85% 26
2019
Q2
$2.94M Sell
36,683
-4,938
-12% -$378K 0.87% 25
2019
Q1
$3.3M Sell
41,621
-1,600
-4% -$120K 0.89% 25
2018
Q4
$3.15M Sell
43,221
-21,185
-33% -$1.5M 0.94% 23
2018
Q3
$4.36M Sell
64,406
-86
-0.1% -$5.48K 0.57% 42
2018
Q2
$3.73M Buy
64,492
+122
+0.2% +$6.88K 0.53% 52
2018
Q1
$3.35M Sell
64,370
-795
-1% -$42.9K 0.5% 53
2017
Q4
$3.5M Buy
65,165
+173
+0.3% +$9.59K 0.48% 59
2017
Q3
$3.97M Buy
64,992
+55
+0.1% +$3.33K 0.6% 45
2017
Q2
$3.97M Sell
64,937
-130
-0.2% -$7.91K 0.64% 43
2017
Q1
$3.94M Buy
65,067
+136
+0.2% +$8.25K 0.66% 45
2016
Q4
$3.65M Sell
64,931
-836
-1% -$48.9K 0.66% 38
2016
Q3
$3.92M Buy
65,767
+18
+0% +$1.05K 0.74% 32
2016
Q2
$3.61M Sell
65,749
-168
-0.3% -$8.94K 0.7% 34
2016
Q1
$3.33M Sell
65,917
-378
-0.6% -$18.5K 0.7% 32
2015
Q4
$3.34M Sell
66,295
-38
-0.1% -$1.92K 0.7% 32
2015
Q3
$3.13M Sell
66,333
-1,391
-2% -$73.9K 0.65% 34
2015
Q2
$3.68M Buy
67,724
+7,378
+12% +$414K 0.67% 32
2015
Q1
$3.31M Buy
60,346
+772
+1% +$43.7K 0.68% 29
2014
Q4
$3.23M Buy
59,574
+1,576
+3% +$87.8K 0.66% 29
2014
Q3
$3.28M Sell
57,998
-27,081
-32% -$1.52M 0.74% 24
2014
Q2
$4.7M Buy
85,079
+1,133
+1% +$61.8K 1.08% 12
2014
Q1
$4.55M Buy
83,946
+26,922
+47% +$1.39M 1.12% 13
2013
Q4
$2.72M Sell
57,024
-1,688
-3% -$77.2K 0.71% 29
2013
Q3
$2.67M Sell
58,712
-37,823
-39% -$1.73M 0.75% 31
2013
Q2
$4.28M Buy
+96,535
New +$4.31M 1.15% 14

Other funds holding MRK

ClearArc Capital's MRK Position: Q4 2019 in Review

ClearArc Capital reduced its Merck (MRK) stake by 32% in Q4 2019, selling an estimated $964K and leaving 24,892 shares worth $2.16M. The position accounts for 0.84% of the portfolio, ranked #26.

ClearArc Capital first reported a position in MRK in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.7M in Q2 2014. 2,537 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

  • ClearArc Capital held 24,892 shares of Merck worth $2.16M as of Q4 2019.
  • ClearArc Capital sold 11,731 Merck shares in Q4 2019, an estimated $964K.
  • Merck made up 0.84% of ClearArc Capital's portfolio in Q4 2019, its #26 holding.
  • ClearArc Capital first reported a position in Merck in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Merck position peaked at $4.7M in Q2 2014.
  • 2,537 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.